// App-Quantinova.ai

e21056 : Melapred: first susceptibility test to sporadic melanoma in daily dermatological practice.

Researchers

Presenter

  • Nadem Soufir

Principal Investigators

  • Steven Gazal

  • Vincent Descamps

  • Nika Madjlessi

  • Celeste Lebbe

  • Nicole Basset-Seguin

  • Alain Archimbaud

  • Kristina Opletalova

  • Valerie Vuong

  • Caroline Nicaise Bergere

  • Sandrine Massart-Manil

  • Bruno Machuel

  • Philippe Saiag

  • Yacine Merrouche

  • Armand Bensussan

  • Eduardo Nagore

  • Rajiv Kumar

  • Florent Grange

Medical Centers

  • Skin Research Center (U976), Saint louis Hospital, Paris, France

  • Department of genetics, Bichat Hospital, Paris, France

  • Department of genetics, Bichat Hospital, Paris, France

  • Department of Dermatology, Bichat Hospital, Paris, France

  • Private, Dermatology, Neuilly Sur Seine, France

  • Dermatology Department, Saint Louis Hospital, Paris, France

  • Department of Dermatology, Saint Louis Hospital, 75010, France

  • Private Dermatology, Villiers Le Bel, France

  • Private Dermatology, Reims, France

  • Private Dermatology, Reims, France

  • Private General Practitioner, Rilly La Montagne, France

  • Department of Dermatology, Ambroise Pare Hospital, Boulogne-Billancourt, France

  • Laboratory of Medical Biology, Jean-Godinot Institue, Reims, France

  • INSERM, Paris, France

  • Instiuto Valenciano de Oncologia, Valencia, Spain

  • Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia

  • Reims University Hospital, Reims, France

Locations

  • France

  • Spain

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved